Learn how our Opto CLD workflow can help remove the bottleneck from traditional cell line development.
Watch a 1-hour webinar from the 2018 BioProcess International Digital Week titled, “Implementing the Beacon Platform for the Next Generation of Cell Line Development,” featuring scientists from Berkeley Lights and Catalent Biologics.
Read this application note to learn more about how to get early, multi-parameter assessment of clones with the Opto Assure assay series.
See how the Opto CLD 2.0 Workflow enables rapid generation of cell lines secreting antibodies for both traditional and non-traditional antibodies while acquiring a superior data package.